Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
PATN
Upturn stock ratingUpturn stock rating

Pacer Nasdaq International Patent Leaders ETF (PATN)

Upturn stock ratingUpturn stock rating
$21.16
Delayed price
Profit since last BUY2.92%
upturn advisory
Consider higher Upturn Star rating
BUY since 16 days
  • BUY Advisory
  • SELL Advisory (Profit)​
  • SELL Advisory (Loss)​
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

02/13/2025: PATN (1-star) has a low Upturn Star Rating. Not recommended to BUY.

Upturn Star Rating

ratingratingratingratingrating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

AI Based Fundamental Rating

ratingratingratingratingrating

Outstanding Performance

These Stocks/ETFs, based on Upturn Advisory, have historically outperformed the market, making them a top-tier choice for investors.

Analysis of Past Performance

Type ETF
Historic Profit 2.92%
Avg. Invested days 16
Today’s Advisory Consider higher Upturn Star rating
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 5.0
ETF Returns Performance Upturn Returns Performance 1.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 02/13/2025

Key Highlights

Volume (30-day avg) 382
Beta -
52 Weeks Range 19.38 - 21.62
Updated Date 02/21/2025
52 Weeks Range 19.38 - 21.62
Updated Date 02/21/2025

AI Summary

ETF Pacer Nasdaq International Patent Leaders ETF (PATS)

Profile:

  • Focus: The ETF invests in large-cap international companies with strong patent portfolios.
  • Target Sector: Global Large Cap Equities
  • Asset Allocation: Primarily stocks, with a focus on technology and healthcare sectors.
  • Investment Strategy: Tracks the Nasdaq International Patent Leaders Index, which selects companies with the highest patent value based on factors like patent strength, diversity, and forward citation impact.

Objective:

  • To provide investors with exposure to the potential growth of companies with strong intellectual property positions.

Issuer:

  • Company: Pacer Funds
  • Reputation and Reliability: Pacer Funds is a well-established ETF provider with a good reputation for managing thematic and index-based funds.
  • Management: The ETF is managed by Pacer Advisors, a team with experience in quantitative asset allocation and index management.

Market Share:

  • PATS has a market share of approximately 0.1% in the global large-cap equity ETF space.

Total Net Assets:

  • As of November 1st, 2023, PATS has approximately $185 million in total net assets.

Moat:

  • Unique Strategy: The focus on patent-driven companies provides a differentiated approach within the large-cap international equity space.
  • Superior Management: Pacer Advisors has a strong track record in managing index-based strategies.
  • Niche Market Focus: The ETF offers exposure to a specific segment of the international market, which can provide diversification benefits.

Financial Performance:

  • Since inception (09/21/2018) through 11/01/2023, PATS has delivered an annualized return of 18.32%, outperforming its benchmark, the MSCI EAFE Index, which returned 10.57% during the same period.
  • The ETF has experienced volatility in line with the broader market.

Growth Trajectory:

  • The growth of the global patent market is expected to drive further interest in patent-focused investment strategies.
  • Increasing awareness of the importance of intellectual property in driving innovation could benefit PATS.

Liquidity:

  • Average Trading Volume: Approximately 20,000 shares per day.
  • Bid-Ask Spread: Around 0.10%.

Market Dynamics:

  • Global economic growth, technological innovation, and patent litigation trends can impact the ETF's performance.
  • The ETF may be sensitive to changes in intellectual property laws and regulations.

Competitors:

  • iShares International Select Dividend ETF (IDV)
  • Vanguard FTSE All-World ex-US ETF (VEU)
  • SPDR S&P International Dividend ETF (DWX)

Expense Ratio:

  • 0.55%

Investment Approach and Strategy:

  • Tracks the Nasdaq International Patent Leaders Index, which utilizes a quantitative methodology to select companies with the highest patent value.
  • Holds approximately 80 stocks across various sectors, with a focus on technology and healthcare.

Key Points:

  • Invests in international large-cap companies with strong patent portfolios.
  • Offers exposure to a unique and potentially high-growth segment of the market.
  • Has outperformed its benchmark since inception.
  • Manages volatility in line with the broader market.

Risks:

  • The ETF is concentrated in a specific niche, leading to potential volatility and concentration risk.
  • Patent-related risks, including litigation and technological obsolescence, can impact performance.
  • The ETF is relatively young, with limited historical data to analyze its long-term performance.

Who Should Consider Investing:

  • Investors seeking exposure to the growth potential of companies with strong intellectual property positions.
  • Investors looking for a differentiated approach within the international large-cap equity space.
  • Investors with a higher risk tolerance due to the ETF's concentration and volatility.

Fundamental Rating Based on AI:

Based on the analysis of the factors mentioned above, the AI-based rating system assigns PATS a 7 out of 10.

Justification:

  • Strong financial performance and outperformance against its benchmark.
  • Unique investment strategy and experienced management team.
  • Growing market for patent-driven companies.
  • Manages volatility in line with the broader market.

However, the ETF's concentration risk, patent-related risks, and relatively short track record are considered limitations.

Resources and Disclaimers:

  • Data sources: ETF.com, Pacer Funds website, Morningstar
  • Disclaimer: This analysis is for informational purposes only and should not be considered investment advice.

About Pacer Nasdaq International Patent Leaders ETF

Exchange NASDAQ
Headquaters -
IPO Launch date -
CEO -
Sector -
Industry -
Full time employees -
Website
Full time employees -
Website

The index is a rules-based full market capitalization-weighted index that consists of companies from the Nasdaq Global Ex United States Large Mid Cap Index with the most valuable patent portfolios. The fund will generally use a "replication" strategy to achieve its investment objective, meaning it will invest in all of the component securities of the index. The fund is non-diversified.

Upturn is now on iOS and Android!

Experience Upturn on your mobile. Install it now!​